ROSE_2C: ROSE, figure 2C

ROSE_2CR Documentation

ROSE, figure 2C

Description

Kaplan-Meier digitized data from ROSE, figure 2C (PMID 25185099). A reported sample size of 1,144 for a primary endpoint of PFS in breast cancer.

Usage

ROSE_2C

Format

A data frame of 1,144 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (pbo_doc, ram_doc)

Source

Mackey JR, Ramos-Vazquez M, Lipatov O, et al. Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer. J Clin Oncol 2015; 33: 141–8.

Examples

summary(ROSE_2C)

kmplot(ROSE_2C)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.